EGFR and K-RAS mutations and ERCC1, TUBB3, TYMS, RRM1 and EGFR mRNA expression in nonsmall cell lung cancer: Correlation with clinical response to gefitinib or chemotherapy

Author:                    

Publisher: Science Publishers

ISSN: 2049-9450

Source: Molecular and Clinical Oncology, Vol.3, Iss.5, 2015-01, pp. : 1123-1128

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content